GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

argenx NV ADR ARGX · USD

Health Care · US listing · 🇺🇸 United States

Compare

962.27

+3.78%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2025

Revenue

$4.15bn

FY2016FY2025

Net income

$1.29bn

FY2016FY2025

Free cash flow

$844.3m

FY2016FY2025

Shareholders' equity

$7.32bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue$4.15bn$2.19bn$1.42bn$474.0m$1.24bn$47.6m$90.6m$28.4m$50.4m$17.9m
Research and development$1.36bn$983.4m$991.9m$765.6m$670.0m$427.6m$254.8m$110.4m$71.6m$38.3m
Operating income$1.05bn−$21.7m−$490.5m−$831.3m−$460.1m−$697.0m−$229.5m−$108.1m−$31.8m−$26.0m
Net income$1.29bn$833.0m−$340.5m−$818.9m−$471.2m−$702.2m−$209.1m−$88.0m−$38.9m−$25.9m
Diluted earnings per share19.5211.74-5.84-14.81-9.15-14.06-5.30-2.55-1.42-1.28

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets$8.68bn$6.20bn$5.24bn$3.62bn$3.29bn$2.63bn$1.86bn$763.7m$513.5m$128.4m
Cash and short-term investments$4.44bn$3.38bn$3.67bn$2.53bn$2.70bn$2.30bn$1.73bn$745.3m$498.1m$117.4m
Total liabilities$1.36bn$704.2m$513.5m$370.0m$364.8m$698.6m$496.0m$52.9m$36.0m$51.5m
Debt$10.8m$6.5m$5.4m$3.9m$4.0m$4.0m$2.6m$1——
Shareholders' equity$7.32bn$5.50bn$4.73bn$3.25bn$2.92bn$1.93bn$1.36bn$710.8m$477.6m$76.9m
Shares outstanding66m71m58m55m52m50m39m34m27m20m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations$850.5m−$82.7m−$485.1m−$995.8m−$700.3m−$459.9m$175.0m−$71.1m−$50.6m$12.9m
Capital spending−$6.2m−$68.3m−$50.6m−$119.8m−$140.1m−$5.9m−$53.9m−$902,505−$485,875−$1.0m
Free cash flow$844.3m−$151.0m−$535.7m−$1.12bn−$840.5m−$465.8m$121.1m−$72.0m−$51.1m$11.8m
Dividends paid———−$6.3m——————

Growth per year

Compound annual rate

3 years5 years10 years
Revenue106.2%144.4%85.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin16.3%-3.5%-15.2%-19.1%
Net margin33.5%11.7%-2.2%-6.1%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Price to earnings43.152.4-65.1-25.6-38.3-20.9-30.3-37.6-44.6
Price to sales13.419.915.744.214.5308.670.0116.834.4

Market value over time

31 May 2017 to 14 Sept 2026, in USD

$896.5m$63.80bn

Share price return

Finished calendar years

202520242023202220212020201920182017
Return36%38%20%12%10%90%74%62%149%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.